Kidney function after nonmyeloablative hematopoietic cell transplant for sickle cell disease
Ataga KI, Saraf SL, Derebail VK. The nephropathy of sickle cell trait and sickle cell disease. Nat Rev Nephrol. 2022;18:361–77.
Google Scholar
Saraf SL, Zhang X, Kanias T, Lash JP, Molokie RE, Oza B, et al. Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol. 2014;164:729–39.
Google Scholar
Yeruva SL, Paul Y, Oneal P, Nouraie M. Renal failure in sickle cell disease: prevalence, predictors of disease, mortality and effect on length of hospital stay. Hemoglobin. 2016;40:295–9.
Google Scholar
Olaniran KO, Allegretti AS, Zhao SH, Nigwekar SU, Kalim S. Acute kidney injury among black patients with sickle cell trait and sickle cell disease. Clin J Am Soc Nephrol. 2021;16:348–55.
Google Scholar
Powars D, Chan L, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Hemoglobin. 2005;84:363–76.
Sharpe C, Thein S. Sickle cell nephropathy – a practical approach. Br J Haematol. 2011;155:287–97.
Google Scholar
Airy M, Eknoyan G. The kidney in sickle hemoglobinopathies. Clin Nephrol. 2017;87:55–68.
Google Scholar
Elmariah H, Garrett M, De Castro L, Jonassaint J, Ataga K, Eckman J, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014;89:530–5.
Google Scholar
Powars D, Elliott-Mills D, Chan L, Niland J, Hiti A, Opas L, et al. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115:614–20.
Google Scholar
Zahr RS, Ataga KI, Lebensburger JD, Winer JC. Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System. Pediatr Nephrol. 2024;39:619–23.
Google Scholar
Saddadi F, Hakemi M, Najafi I, Moghadam K, Ghavamzadeh A, Jahani M, et al. Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes. Transpl Proc. 2009;41:2895–7.
Google Scholar
Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD. Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transpl. 2008;8:2378–90.
Google Scholar
Touzot M, Elie C, van Massenhove J, Maillard N, Buzyn A, Fakhouri F. Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study. Nephrol Dialysis Transpl. 2010;25:624–7.
Google Scholar
Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481–508.
Google Scholar
Hingorani S, Pao E, Stevenson P, Schoch G, Laskin BL, Gooley T, et al. Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: a prospective cohort study. Clin J Am Soc Nephrol. 2018;13:866–73.
Google Scholar
Hingorani SR, Seidel K, Lindner A, Aneja T, Schoch G, McDonald G. Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transpl. 2008;14:1365–72.
Google Scholar
Kersting S, Verdonck L. Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction. Biol Blood Marrow Transpl. 2008;14:1312–6.
Google Scholar
Zager RA, O’Quigley J, Zager BK, Alpers CE, Shulman HM, Gamelin LM, et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis. 1989;13:210–6.
Google Scholar
Kanduri SR, Cheungpasitporn W, Thongprayoon C, Bathini T, Kovvuru K, Garla V, et al. Incidence and mortality of acute kidney injury in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. QJM. 2020;113:621–32.
Google Scholar
Pedersen SJV, Monagel DA, Mammen C, Lewis VA, Guilcher GMT, Bruce AA. Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2020;67:e28568.
Google Scholar
Krishnamurti L, Kharbanda S, Biernacki MA, Zhang W, Baker KS, Wagner JE, et al. Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transpl. 2008;14:1270–8.
Google Scholar
Matthes-Martin S, Lawitschka A, Fritsch G, Lion T, Grimm B, Breuer S, et al. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease. Eur J Haematol. 2013;90:308–12.
Google Scholar
Dallas MH, Triplett B, Shook DR, Hartford C, Srinivasan A, Laver J, et al. Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transpl. 2013;19:820–30.
Google Scholar
Delgado C, Baweja M, Crews DC, Eneanya ND, Gadegbeku CA, Inker LA, et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN task force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis. 2022;79:268–88.e1.
Google Scholar
Selistre L, Rabilloud M, Cochat P, de Souza V, Iwaz J, Lemoine S, et al. Comparison of the Schwartz and CKD-EPI equations for estimating glomerular filtration rate in children, adolescents, and adults: a retrospective cross-sectional study. PLoS Med. 2016;13:e1001979.
Google Scholar
Levey AS, Inker LA, Matsushita K, Greene T, Willis K, Lewis E, et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis. 2014;64:821–35.
Google Scholar
Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2012;158:825–30.
Google Scholar
Ephraim R. Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana. BMC Nephrol. 2015;16:75.
Google Scholar
KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements [Internet]. 2012; 2. Available from: https://kdigo.org/guidelines/acute-kidney-injury/.
Derebail V, Ciccone E, Zhou Q, Kilgore R, Cai J, Ataga K. Progressive Decline in Estimated GFR in Patients with Sickle Cell Disease: An Observational Cohort Study. Am J Kidney Dis. 2019;74:47–55.
Google Scholar
Dovern E, Aydin M, DeBaun MR, Alizade K, Biemond BJ, Nur E. Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease-related organ complications: a systematic review and meta-analysis. Am J Hematol. 2024;99:1129–41.
Google Scholar
Lebensburger JD, Derebail VK. Sickle cell disease and the kidney. Filters Gone Awry Hematol Oncol Clin North Am 2022;36:1239–54.
Google Scholar
Hoste E, Clermont G, Kersten A, Venkataraman R, Angus D, De Bacquer D, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically Ill patients: a cohort analysis. Crit Care. 2006;10:R73.
Google Scholar
Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–7.
Google Scholar
Renaghan AD, Jaimes EA, Malyszko J, Perazella MA, Sprangers B, Rosner MH. Acute kidney injury and CKD associated with hematopoietic stem cell transplantation. Clin J Am Soc Nephrol. 2020;15:289–97.
Google Scholar
Fitzhugh CD, Volanakis EJ, Idassi O, Duberman JA, DeBaun MR, Friedman DL. Long-term health effects of curative therapies on heart, lungs, and kidneys for individuals with sickle cell disease compared to those with hematologic malignancies. J Clin Med. 2022;11:3118.
Google Scholar
Asnani M, Reid M. Cystatin C: a useful marker of glomerulopathy in sickle cell disease? Blood Cells Mol Dis. 2015;54:65–70.
Google Scholar
Yee M, Lane P, Archer D, Joiner C, Eckman J, Guasch A. Estimation of glomeruloar filtration rate using serum cystatin C and creatinine in adults with sickle cell anemia. Am J Hematol. 2017;92:E598–E9.
Google Scholar
Alvarez O, Zilleruelo G, Wright D, Montane B, Lopez-Mitnik G. Serum cystatin C levels in children with sickle cell disease. Pediatr Nephrol. 2006;21:533–7.
Google Scholar
Barreto M, Limerick E, Jeffries N, Varga J, Gharib A, Clark M, et al. Creatinine-based estimating equations for GFR outperform cystatin C-based equations in adults with sickle cell disease. Foundation for Sickle Cell Research; Fort Lauderdale, FL (2023).
link
